Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections
Emily Zoller, Connie Valente, Kyle Baker, Michael E KlepserFerris State University College of Pharmacy, Kalamazoo, Michigan, USAAbstract: Posaconazole is an extended-spectrum azole antifungal that exhibits activity against a broad range of fungal pathogens, including yeasts and moulds. Clinical data...
Main Authors: | Emily Zoller, Connie Valente, Kyle Baker, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-11-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/development-clinical-utility-and-place-in-therapy-of-posaconazole-for--a5594 |
Similar Items
-
Posaconazole in the management of refractory invasive fungal infections
by: Stefan Langner, et al.
Published: (2008-09-01) -
Comparative pharmacoeconomic analysis of posaconazole therapy in tablet form and in suspension for invasive fungal infections prevention
by: I. S. Krysanov, et al.
Published: (2021-06-01) -
Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole
by: Soysal A
Published: (2015-09-01) -
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole
by: Sze-Hwei Lee, et al.
Published: (2016-05-01) -
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection
by: Sarah Allegra, et al.
Published: (2017-11-01)